Fujirebio Diagnostics

Fujirebio Diagnostics is a leader in cancer biomarker assays and in vitro diagnostics. Their products support early detection and monitoring of disease, aiding clinicians in making informed treatment decisions.

Content by Fujirebio Diagnostics

Fujirebio Diagnostics Files 510(K) with FDA for Lumipulse® G ?-Amyloid Ratio (1-42/1-40) in Vitro Diagnostic Test
| 2 min read
Page 1 of 1 - 1 Total Items

CURRENT ISSUE - January/February 2026

How to Build Trust Into Every Lab Result

Applying the Six Cs Helps Labs Deliver Results Stakeholders Can Rely On

Lab Manager January/February 2026 Cover Image